Abstract
Different agent-based models have been developed to estimate the spread progression of coronavirus disease 2019 (COVID-19) and to evaluate different control strategies to control outbreak of the infectious disease. While there are several estimation methods for the disease-specific parameters of COVID-19, they have been used for aggregate level models such as SIR and not for agent-based models. We propose a mathematical structure to determine parameter values of agent-based models considering the mutual effects of parameters. Then, we assess the extent to which different control strategies can intervene the transmission of COVID-19. Accordingly, we consider scenarios of easing social distancing restrictions, opening businesses, speed of enforcing control strategies and quarantining family members of isolated cases on the disease progression. We find the social distancing compliance level in the Sydney greater metropolitan area to be around 85%. Then we elaborate on consequences of easing the compliance level in the disease suppression. We also show that tight social distancing levels should be considered when the restrictions on businesses and activity participations are easing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no specific funding source for this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There is no oversight body.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data which we have addressed to is available.